These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3159215)

  • 1. Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological intervention.
    Fuster V; Chesebro JH
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():285-99. PubMed ID: 3159215
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting.
    Poston RS; Gu J; Brown JM; Gammie JS; White C; Nie L; Pierson RN; Griffith BP
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):122-30. PubMed ID: 16399303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-inhibitory therapy in reconstructive arterial surgery.
    McCollum CN; Goldman M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():301-9. PubMed ID: 3159216
    [No Abstract]   [Full Text] [Related]  

  • 5. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors.
    Solymoss BC; Nadeau P; Millette D; Campeau L
    Circulation; 1988 Sep; 78(3 Pt 2):I140-3. PubMed ID: 3261650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein.
    Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of magnesium and potassium in the pathogenesis of arteriosclerosis.
    Rayssiguier Y
    Magnesium; 1984; 3(4-6):226-38. PubMed ID: 6399344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
    Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.
    Yilmaz MB; Balbay Y; Caldir V; Ayaz S; Guray Y; Guray U; Korkmaz S
    Thromb Res; 2005; 115(1-2):25-9. PubMed ID: 15567449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical impact of atherosclerotic saphenous vein to coronary artery bypass grafts.
    Lytle BW
    Semin Thorac Cardiovasc Surg; 1994 Apr; 6(2):81-6. PubMed ID: 8025142
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of the arterial smooth muscle cell in the pathogenesis of atherosclerosis.
    Pietilä K; Nikkari T
    Med Biol; 1983 Feb; 61(1):31-44. PubMed ID: 6341723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac saphenous vein bypass graft disease.
    Lau GT; Lowe HC; Kritharides L
    Semin Vasc Med; 2004 May; 4(2):153-9. PubMed ID: 15478036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic cellular mechanisms of coronary bypass graft disease.
    Yang Z; Lüscher TF
    Eur Heart J; 1993 Nov; 14 Suppl I():193-7. PubMed ID: 8293775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
    Gitler B; Gitler ES
    Am Heart J; 1983 Sep; 106(3):563-70. PubMed ID: 6410893
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural features of cell death in atherosclerotic lesions affecting long-term aortocoronary saphenous vein bypass grafts.
    Wang AY; Bobryshev YV; Cherian SM; Liang H; Inder SJ; Lord RS; Ashwell KW; Farnsworth AE
    J Submicrosc Cytol Pathol; 1999 Jul; 31(3):423-32. PubMed ID: 10626009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
    Moor E; Silveira A; van't Hooft F; Tornvall P; Blombäck M; Wiman B; Rydén L; Hamsten A
    Thromb Haemost; 1998 Aug; 80(2):220-4. PubMed ID: 9716141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue.
    Jabs WJ; Theissing E; Nitschke M; Bechtel JF; Duchrow M; Mohamed S; Jahrbeck B; Sievers HH; Steinhoff J; Bartels C
    Circulation; 2003 Sep; 108(12):1428-31. PubMed ID: 12975260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
    Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
    Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.